ARE |
Antioxidant response element |
AT II |
Angiotensin II |
ATP III |
National Cholesterol Education Program’s Adult Treatment Panel III report |
BMI |
Body mass index |
CAT |
Catalase |
CD36 |
Cluster determinant 36 |
CD38 |
Cluster of differentiation 38 |
CETP |
Cholesterol ester transport protein |
CHD |
Coronary heart disease |
Cmax
|
Maximum concentration |
CVD |
Cardiovascular diseases |
EGIR |
European Group for the Study of Insulin Resistance |
FFA |
Free fatty acids |
GPX |
Glutathione peroxidase |
GSH |
Glutathione |
HDL |
High-density lipoproteins |
HF |
Heart failure |
I/R |
Ischaemia/reperfusion |
IDF |
International Diabetes Federation |
IL |
Interleukin |
IL-6 |
Interleukin 6 |
ISO |
Isoproterenol |
Keap1 |
Kelch-like ECH-associated protein 1 |
LDL |
Low-density lipoproteins |
M1 |
Macrophages 1 |
M2 |
Macrophages 2 |
MRP |
Multidrug resistance proteins |
MW |
Molecular weight |
NAD |
Nicotinamide adenine dinucleotide |
NF-kB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
NHANES |
National Health and Nutritional Examination Survey |
NO |
Nitric oxide |
NAFLD |
Non-alcoholic Fatty Liver Disease |
Nrf2 |
Nuclear factor erythroid 2-related factor 2 |
PPARγ |
Peroxisomes proliferator activated receptor gamma |
SIRT1 |
Sirtuin-1 |
SOD |
Superoxide dismutase |
STAT 3 |
Signal transducer and activator of transcription 3 |
TGs |
Triglycerides |
TNF |
Tumour Necrosis factor |
TXNRD |
Thioredoxin reductase |
VLDL |
Very low-density lipoproteins |
VO |
Visceral obesity |
WHO |
World Health Organization |